Relationship of genetic type of Shiga toxin to manifestation of bloody diarrhea due to enterohemorrhagic Escherichia coli serogroup O157 isolates in Osaka City, Japan

Journal of Clinical Microbiology

Volumn 38, Issue 6, 2000, Pages 2440-2442

  Nishikawa, Y ^a   Zhou, Z ^a,c   Hase, A ^a   Ogasawara, J ^a   Cheasty, T ^b   Haruki, K ^a  

^a OSAKA CITY INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^c CHANGCHUN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SHIGA TOXIN;

ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; DIARRHEA; ESCHERICHIA COLI O157; GENOTYPE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 0034086152     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.6.2440-2442.2000     Document Type: Article

References (20)

1. Cao, C., S. Yamasaki, Z. Lin, H. Kurazono, and Y. Takeda. 1994. Specific detection of a Verotoxin 2 variant, VT2vp1, by a bead-enzyme-linked immunosorbent assay. Microbiol. Immunol. 38:435-440.
2. Johnson, W. M., H. Lior, and G. S. Bezanson. 1983. Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada. Lancet i:76.
3. Johnson, W. M., S. D. Tyler, G. Wang, and H. Lior. 1991. Amplification by the polymerase chain reaction of a specific target sequence in the gene coding for Escherichia coli verotoxin (VTe variant). FEMS Microbiol. Lett. 84:227-230.
4. Karmali, M. A. 1989. Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2:15-38.
5. Karmali, M. A., M. Petric, and M. Bielaszewska. 1999. Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli. J. Clin. Microbiol. 37:396-399.
6. Keenan, K. P., D. D. Sharpnack, H. Collins, S. B. Formal, and A. D. O'Brien. 1986. Morphologic evaluation of the effects of Shiga toxin and Escherichia coli Shiga-like toxin on the rabbit intestine. Am. J. Pathol. 125:69-80.
7. Marques, L. R. M., M. A. Moore, J. G. Wells, I. K. Wachsmuth, and A. D. O'Brien. 1986. Production of Shiga-like toxin by Escherichia coli. J. Infect. Dis. 154:338-341.
8. O'Brien, A. D., G. D. LaVeck, M. R. Thompson, and S. B. Formal. 1982. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J. Infect. Dis. 146:763-769.
9. Ostroff, S. M., P. I. Tarr, M. A. Neill, J. H. Lewis, N. Hargrett-Bean, and J. M. Kobayashi. 1989. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J. Infect. Dis. 160:994-998.
10. Pai, C. H., J. K. Kelly, and G. L. Meyers. 1986. Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect. Immun. 51: 16-23.
11. Riley, L. W. 1987. The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis. Annu. Rev. Microbiol. 41:383-407.
12. Riley, L. W., R. S. Remis, S. D. Helgerson, H. B. McGee, J. G. Wells, B. R. Davis, R. J. Hebert, E. S. Olcott, L. M. Johnson, N. T. Hargrett, P. A. Blake, and M. L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685.
13. Samuel, J. E., L. P. Perera, S. Ward, A. D. O'Brien, V. Ginsburg, and H. C. Krivan. 1990. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Infect. Immun. 58: 611-618.
14. Scotland, S. M., H. R. Smith, and B. Rowe. 1985. Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet ii:885-886.
15. Smith, H. R., and S. M. Scotland. 1988. Vero cytotoxin-producing strains of Escherichia coli. J. Med. Microbiol. 26:77-85.
16. Takeda, Y., H. Kurazono, and S. Yamasaki. 1993. Vero toxins (Shiga-like toxins) produced by enterohemorrhagic Escherichia coli (Verocytotoxin-producing E. coli). Microbiol. Immunol. 37:591-599.
17. Tarr, P. I. 1995. Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin. Infect. Dis. 20:1-10.
18. Tyler, S. D., W. M. Johnson, H. Lior, G. Wang, and K. R. Rozee. 1991. Identification of verotoxin type 2 variant b subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis. J. Clin. Microbiol. 29:1339-1343.
19. Tzipori, S., H. Karch, K. I. Wachsmuth, R. M. Robins-Browne, A. D. O'Brien, H. Lior, M. L. Cohen, J. Smithers, and M. M. Levine. 1987. Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. Infect. Immun. 55:3117-3125.
20. Waddell, T., S. Head, M. Petric, A. Cohen, and C. Lingwood. 1988. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem. Biophys. Res. Commun. 152:674-679.